The global Molecular Diagnostic Chip market size is predicted to grow from US$ 7578 million in 2025 to US$ 10387 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Molecular diagnostic chips are miniature laboratory platforms designed for the rapid and accurate detection of genetic and nucleic acid biomarkers, widely used in early disease diagnosis, personalized therapy, and infectious disease detection.
United States market for Molecular Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Molecular Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Molecular Diagnostic Chip is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Molecular Diagnostic Chip players cover Thermo Fisher Scientific, Roche Diagnostics, Illumina, Agilent Technologies, Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淢olecular Diagnostic Chip Industry Forecast鈥 looks at past sales and reviews total world Molecular Diagnostic Chip sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Diagnostic Chip sales for 2025 through 2031. With Molecular Diagnostic Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Diagnostic Chip industry.
This Insight Report provides a comprehensive analysis of the global Molecular Diagnostic Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Molecular Diagnostic Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global Molecular Diagnostic Chip market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Diagnostic Chip and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Diagnostic Chip.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Diagnostic Chip market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Gene Expression Analysis Chips
SNP Genotyping Chips
Pathogen Detection Chips
Cancer Molecular Diagnostic Chips
Others
Segmentation by Application:
Early Cancer Screening and Diagnosis
Infectious Disease Detection
Genetic Disease Screening
Personalized Medication Guidance
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Roche Diagnostics
Illumina
Agilent Technologies
Bio-Rad Laboratories
Siemens Healthineers
Qiagen
Abbott Laboratories
GE Healthcare
PerkinElmer
Sysmex Corporation
产颈辞惭茅谤颈别耻虫
Becton, Dickinson and Company
Merck KGaA
Nanosphere Inc.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Molecular Diagnostic Chip market?
What factors are driving Molecular Diagnostic Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Molecular Diagnostic Chip market opportunities vary by end market size?
How does Molecular Diagnostic Chip break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Molecular Diagnostic Chip Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Molecular Diagnostic Chip by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Molecular Diagnostic Chip by Country/Region, 2020, 2024 & 2031
2.2 Molecular Diagnostic Chip Segment by Type
2.2.1 Gene Expression Analysis Chips
2.2.2 SNP Genotyping Chips
2.2.3 Pathogen Detection Chips
2.2.4 Cancer Molecular Diagnostic Chips
2.2.5 Others
2.3 Molecular Diagnostic Chip Sales by Type
2.3.1 Global Molecular Diagnostic Chip Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Molecular Diagnostic Chip Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Molecular Diagnostic Chip Sale Price by Type (2020-2025)
2.4 Molecular Diagnostic Chip Segment by Application
2.4.1 Early Cancer Screening and Diagnosis
2.4.2 Infectious Disease Detection
2.4.3 Genetic Disease Screening
2.4.4 Personalized Medication Guidance
2.4.5 Others
2.5 Molecular Diagnostic Chip Sales by Application
2.5.1 Global Molecular Diagnostic Chip Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Molecular Diagnostic Chip Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Molecular Diagnostic Chip Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Molecular Diagnostic Chip Breakdown Data by Company
3.1.1 Global Molecular Diagnostic Chip Annual Sales by Company (2020-2025)
3.1.2 Global Molecular Diagnostic Chip Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Molecular Diagnostic Chip Annual Revenue by Company (2020-2025)
3.2.1 Global Molecular Diagnostic Chip Revenue by Company (2020-2025)
3.2.2 Global Molecular Diagnostic Chip Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Molecular Diagnostic Chip Sale Price by Company
3.4 Key Manufacturers Molecular Diagnostic Chip Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Diagnostic Chip Product Location Distribution
3.4.2 Players Molecular Diagnostic Chip Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Molecular Diagnostic Chip by Geographic Region
4.1 World Historic Molecular Diagnostic Chip 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Molecular Diagnostic Chip Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Molecular Diagnostic Chip Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Molecular Diagnostic Chip 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Molecular Diagnostic Chip Annual Sales by Country/Region (2020-2025)
4.2.2 Global Molecular Diagnostic Chip Annual Revenue by Country/Region (2020-2025)
4.3 Americas Molecular Diagnostic Chip Sales Growth
4.4 APAC Molecular Diagnostic Chip Sales Growth
4.5 Europe Molecular Diagnostic Chip Sales Growth
4.6 Middle East & Africa Molecular Diagnostic Chip Sales Growth
5 Americas
5.1 Americas Molecular Diagnostic Chip Sales by Country
5.1.1 Americas Molecular Diagnostic Chip Sales by Country (2020-2025)
5.1.2 Americas Molecular Diagnostic Chip Revenue by Country (2020-2025)
5.2 Americas Molecular Diagnostic Chip Sales by Type (2020-2025)
5.3 Americas Molecular Diagnostic Chip Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Diagnostic Chip Sales by Region
6.1.1 APAC Molecular Diagnostic Chip Sales by Region (2020-2025)
6.1.2 APAC Molecular Diagnostic Chip Revenue by Region (2020-2025)
6.2 APAC Molecular Diagnostic Chip Sales by Type (2020-2025)
6.3 APAC Molecular Diagnostic Chip Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molecular Diagnostic Chip by Country
7.1.1 Europe Molecular Diagnostic Chip Sales by Country (2020-2025)
7.1.2 Europe Molecular Diagnostic Chip Revenue by Country (2020-2025)
7.2 Europe Molecular Diagnostic Chip Sales by Type (2020-2025)
7.3 Europe Molecular Diagnostic Chip Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Diagnostic Chip by Country
8.1.1 Middle East & Africa Molecular Diagnostic Chip Sales by Country (2020-2025)
8.1.2 Middle East & Africa Molecular Diagnostic Chip Revenue by Country (2020-2025)
8.2 Middle East & Africa Molecular Diagnostic Chip Sales by Type (2020-2025)
8.3 Middle East & Africa Molecular Diagnostic Chip Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Diagnostic Chip
10.3 Manufacturing Process Analysis of Molecular Diagnostic Chip
10.4 Industry Chain Structure of Molecular Diagnostic Chip
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Diagnostic Chip Distributors
11.3 Molecular Diagnostic Chip Customer
12 World Forecast Review for Molecular Diagnostic Chip by Geographic Region
12.1 Global Molecular Diagnostic Chip 麻豆原创 Size Forecast by Region
12.1.1 Global Molecular Diagnostic Chip Forecast by Region (2026-2031)
12.1.2 Global Molecular Diagnostic Chip Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Molecular Diagnostic Chip Forecast by Type (2026-2031)
12.7 Global Molecular Diagnostic Chip Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific Molecular Diagnostic Chip Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Roche Diagnostics
13.2.1 Roche Diagnostics Company Information
13.2.2 Roche Diagnostics Molecular Diagnostic Chip Product Portfolios and Specifications
13.2.3 Roche Diagnostics Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Roche Diagnostics Main Business Overview
13.2.5 Roche Diagnostics Latest Developments
13.3 Illumina
13.3.1 Illumina Company Information
13.3.2 Illumina Molecular Diagnostic Chip Product Portfolios and Specifications
13.3.3 Illumina Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Illumina Main Business Overview
13.3.5 Illumina Latest Developments
13.4 Agilent Technologies
13.4.1 Agilent Technologies Company Information
13.4.2 Agilent Technologies Molecular Diagnostic Chip Product Portfolios and Specifications
13.4.3 Agilent Technologies Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Agilent Technologies Main Business Overview
13.4.5 Agilent Technologies Latest Developments
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Information
13.5.2 Bio-Rad Laboratories Molecular Diagnostic Chip Product Portfolios and Specifications
13.5.3 Bio-Rad Laboratories Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bio-Rad Laboratories Main Business Overview
13.5.5 Bio-Rad Laboratories Latest Developments
13.6 Siemens Healthineers
13.6.1 Siemens Healthineers Company Information
13.6.2 Siemens Healthineers Molecular Diagnostic Chip Product Portfolios and Specifications
13.6.3 Siemens Healthineers Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Siemens Healthineers Main Business Overview
13.6.5 Siemens Healthineers Latest Developments
13.7 Qiagen
13.7.1 Qiagen Company Information
13.7.2 Qiagen Molecular Diagnostic Chip Product Portfolios and Specifications
13.7.3 Qiagen Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Qiagen Main Business Overview
13.7.5 Qiagen Latest Developments
13.8 Abbott Laboratories
13.8.1 Abbott Laboratories Company Information
13.8.2 Abbott Laboratories Molecular Diagnostic Chip Product Portfolios and Specifications
13.8.3 Abbott Laboratories Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Abbott Laboratories Main Business Overview
13.8.5 Abbott Laboratories Latest Developments
13.9 GE Healthcare
13.9.1 GE Healthcare Company Information
13.9.2 GE Healthcare Molecular Diagnostic Chip Product Portfolios and Specifications
13.9.3 GE Healthcare Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GE Healthcare Main Business Overview
13.9.5 GE Healthcare Latest Developments
13.10 PerkinElmer
13.10.1 PerkinElmer Company Information
13.10.2 PerkinElmer Molecular Diagnostic Chip Product Portfolios and Specifications
13.10.3 PerkinElmer Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 PerkinElmer Main Business Overview
13.10.5 PerkinElmer Latest Developments
13.11 Sysmex Corporation
13.11.1 Sysmex Corporation Company Information
13.11.2 Sysmex Corporation Molecular Diagnostic Chip Product Portfolios and Specifications
13.11.3 Sysmex Corporation Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Sysmex Corporation Main Business Overview
13.11.5 Sysmex Corporation Latest Developments
13.12 产颈辞惭茅谤颈别耻虫
13.12.1 产颈辞惭茅谤颈别耻虫 Company Information
13.12.2 产颈辞惭茅谤颈别耻虫 Molecular Diagnostic Chip Product Portfolios and Specifications
13.12.3 产颈辞惭茅谤颈别耻虫 Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 产颈辞惭茅谤颈别耻虫 Main Business Overview
13.12.5 产颈辞惭茅谤颈别耻虫 Latest Developments
13.13 Becton, Dickinson and Company
13.13.1 Becton, Dickinson and Company Company Information
13.13.2 Becton, Dickinson and Company Molecular Diagnostic Chip Product Portfolios and Specifications
13.13.3 Becton, Dickinson and Company Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Becton, Dickinson and Company Main Business Overview
13.13.5 Becton, Dickinson and Company Latest Developments
13.14 Merck KGaA
13.14.1 Merck KGaA Company Information
13.14.2 Merck KGaA Molecular Diagnostic Chip Product Portfolios and Specifications
13.14.3 Merck KGaA Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Merck KGaA Main Business Overview
13.14.5 Merck KGaA Latest Developments
13.15 Nanosphere Inc.
13.15.1 Nanosphere Inc. Company Information
13.15.2 Nanosphere Inc. Molecular Diagnostic Chip Product Portfolios and Specifications
13.15.3 Nanosphere Inc. Molecular Diagnostic Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Nanosphere Inc. Main Business Overview
13.15.5 Nanosphere Inc. Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.